Aurinia Pharmaceuticals
AUPH
#4752
Rank
HK$16.93 B
Marketcap
HK$127.29
Share price
1.31%
Change (1 day)
41.86%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): HK$1.28 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.31 Billion. In 2025 the company made an earning of HK$0.92 Billion, an increase over its 2024 earnings that were of HK$96.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$1.28 B38.24%
2025 HK$0.92 B864.64%
2024 HK$96.39 M-116.44%
2023 -HK$0.59 Billion-31.8%
2022 -HK$0.86 Billion-39.4%
2021 -HK$1.42 Billion61.9%
2020 -HK$0.88 Billion-9.73%
2019 -HK$0.98 Billion92.65%
2018 -HK$0.51 Billion36.39%
2017 -HK$0.37 Billion106.29%
2016 -HK$0.18 Billion-15.4%
2015 -HK$0.22 Billion65.84%
2014 -HK$0.13 Billion129.82%
2013 -HK$55.53 Million-26.6%
2012 -HK$75.65 Million
2010 -HK$42.83 Million-39.22%
2009 -HK$70.47 Million-43.78%
2008 -HK$0.13 Billion-53.19%
2007 -HK$0.27 Billion42.97%
2006 -HK$0.19 Billion-23.03%
2005 -HK$0.25 Billion36.1%
2004 -HK$0.18 Billion172.57%
2003 -HK$65.61 Million484.61%
2002 -HK$11.23 Million
2000 -HK$53.29 Million453.81%
1999 -HK$9.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
HK$40.54 B 3,041.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-HK$0.18 Billion-113.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-HK$43.05 Million-103.34%๐Ÿ‡บ๐Ÿ‡ธ USA